EGFR and non-small cell lung carcinoma: To investigate whether PAI-1 expression in the tumor tissue increased at the time of acquired resistance to EGFR-TKI, we compared the PAI-1 expression in the tumor specimens before and after acquired resistance to EGFR-TKIs in in patients with EGFR-mutated NSCLC.